SCHEMBL12800982

SCHEMBL12800982

c1ccc2c(c1)nc1n(-c3ccc4[nH]c5ccccc5c4c3)c3ccccc3n21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 1/20 0.40
AHR P35869 1/20 0.39
ALDH1A1 P00352 4/20 0.36
HSD17B10 Q99714 3/20 0.36
GPR3 P46089 1/20 0.36
KDM4E B2RXH2 5/20 0.35
KIF11 P52732 3/20 0.35
HPGD P15428 3/20 0.35
MAPT P10636 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
GABRP O00591 3/20 0.35
GABRD O14764 3/20 0.35
GABRA1 P14867 3/20 0.35
GABRB1 P18505 3/20 0.35
GABRG2 P18507 3/20 0.35
GABRB3 P28472 3/20 0.35
GABRA5 P31644 3/20 0.35
GABRA3 P34903 3/20 0.35
GABRA2 P47869 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30876355 1.00 TOP2A (0.40) TOP2AAHRALDH1A1HSD17B10GPR3
SCHEMBL15631669 0.94 KDM4E (0.35) TOP2AAHRALDH1A1HSD17B10KDM4E
SCHEMBL23219318 0.92 TOP2A (0.40) TOP2AAHRALDH1A1HSD17B10GPR3
SCHEMBL26342598 0.85 CDK4 (0.36) TOP2AALDH1A1HSD17B10KDM4EHPGD
SCHEMBL18830921 0.83 TOP2A (0.36) TOP2AAHRALDH1A1HSD17B10GPR3
SCHEMBL18687112 0.83 HPGD (0.37) TOP2AAHRALDH1A1HSD17B10KDM4E
SCHEMBL18698129 0.83 HPGD (0.37) TOP2AAHRALDH1A1HSD17B10KDM4E
SCHEMBL20616762 0.82 TOP2A (0.41) TOP2AAHRALDH1A1HSD17B10GPR3
SCHEMBL18934348 0.82 TOP2A (0.41) TOP2AAHRALDH1A1HSD17B10GPR3
SCHEMBL23652412 0.82 ADORA2B (0.35) TOP2AAHRALDH1A1HSD17B10GPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024033282-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2024-02-15 WO disclosed
US-20240025927-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2024-01-25 US disclosed
US-20230363276-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-11-09 US disclosed
US-20230329089-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-10-12 US disclosed
US-20230287017-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-09-14 US disclosed
US-11744152-B2 Benzimidazo[1,2-a]benzimidazole derivatives for electronic applications UDC IRELAND LIMITED (IE) 2023-08-29 US disclosed
US-11744152-B2 Benzimidazo[1,2-a]benzimidazole derivatives for electronic applications UDC IRELAND LIMITED (IE) 2023-08-29 US disclosed
US-11744152-B2 Benzimidazo[1,2-a]benzimidazole derivatives for electronic applications UDC IRELAND LIMITED (IE) 2023-08-29 US disclosed
US-20230200212-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-06-22 US disclosed
US-20230192665-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-06-22 US disclosed
EP-2872512-A1 BENZIMIDAZO[1,2-A]BENZIMIDAZOLE DERIVATIVES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2015-05-20 EP disclosed
WO-2015063046-A1 AZADIBENZOTHIOPHENES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2015-05-07 WO disclosed
WO-2015063046-A1 AZADIBENZOTHIOPHENES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2015-05-07 WO disclosed
WO-2015014791-A1 BENZIMIDAZOLO[2,1-B][1,3]BENZOTHIAZOLES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2015-02-05 WO disclosed
WO-2015014791-A1 BENZIMIDAZOLO[2,1-B][1,3]BENZOTHIAZOLES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2015-02-05 WO disclosed
WO-2014044722-A1 AZADIBENZOFURANS FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2014-03-27 WO disclosed
WO-2014009317-A1 BENZIMIDAZO[1,2-A]BENZIMIDAZOLE DERIVATIVES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2014-01-16 WO disclosed
WO-2014009317-A1 BENZIMIDAZO[1,2-A]BENZIMIDAZOLE DERIVATIVES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2014-01-16 WO disclosed
US-20120241681-A1 4H-Imidazo[1,2-a]imidazoles for Electronic Applications BASF SE (DE) 2012-09-27 US disclosed
US-20120241681-A1 4H-Imidazo[1,2-a]imidazoles for Electronic Applications BASF SE (DE) 2012-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120241681-A1 4H-Imidazo[1,2-a]imidazoles for Electronic Applications EIF4A1, ITPR2, ITPR1 TOP2A 2040/4885AHR 2907/4885ALDH1A1 355/4885
US-20230287017-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, NONO TOP2A 3967/4885AHR 608/4885ALDH1A1 702/4885
US-20230200212-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, SIRT2, OCIAD1 TOP2A 4661/4885AHR 3679/4885ALDH1A1 950/4885
US-20230363276-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD1, OCIAD2, ODC1 TOP2A 4512/4885AHR 776/4885ALDH1A1 569/4885
US-20230329089-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES NR1H2, OXER1, NR1H3 TOP2A 4465/4885AHR 1033/4885ALDH1A1 669/4885
US-11744152-B2 Benzimidazo[1,2-a]benzimidazole derivatives for electronic applications PAICS, EIF4A1, ECI1 TOP2A 2042/4885AHR 3738/4885ALDH1A1 122/4885
US-20230192665-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, ODC1 TOP2A 4166/4885AHR 702/4885ALDH1A1 260/4885
US-20240025927-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD1, OCIAD2, ODC1 TOP2A 4836/4885AHR 1318/4885ALDH1A1 525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.